Pharmaceutical Investment

Novartis Commits $23 Billion to Bolster U.S. Pharmaceutical Manufacturing and R&D

In a significant move to enhance its presence in the United States, Swiss pharmaceutical giant Novartis AG has announced a substantial investment of $23...